Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Interleukin-26 (IL-26) is a novel anti-microbial peptide produced by T cells in response to staphylococcal enterotoxin

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Cell-free DNA in newly diagnosed patients with glioblastoma - a clinical prospective feasibility study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. VEGF-C as a putative therapeutic target in cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Application of cell-free DNA for genomic tumor profiling: a feasibility study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Is pseudarthrosis after spinal instrumentation caused by a chronic infection?

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. An Equine Wound Model to Study Effects of Bacterial Aggregates on Wound Healing

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Analysis of proximal bone margins in diabetic foot osteomyelitis by conventional culture, DNA sequencing and microscopy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Antimicrobial Tolerance and Metabolic Adaptations in Microbial Biofilms

    Research output: Contribution to journalReviewResearchpeer-review

  • Anders Woetmann
  • Morten Alhede
  • Sally Dabelsteen
  • Thomas Bjarnsholt
  • Morten Rybtke
  • Claudia Nastasi
  • Thorbjørn Krejsgaard
  • Mads Hald Andersen
  • Charlotte M Bonefeld
  • Carsten Geisler
  • Michael Givskov
  • Niels Odum
View graph of relations

Anti-microbial peptides are produced at outer and inner surfaces by epithelia and innate immune cells in response to bacterial infection. Staphylococcus aureus is an enterotoxin producing, Gram-positive pathogen, which is a major cause of soft tissue infections and life-threatening bacteremia and sepsis. Here we show that (i) skin T cells in chronic wounds infected with S. aureus express interleukin-26 (IL-26) in situ, (ii) staphylococcal enterotoxins (SE) trigger IL-26 expression in T cell lines and primary skin T cells, and (iii) IL-26 triggers death and inhibits biofilm formation and growth of S. aureus. Thus, we provide novel evidence that IL-26 is an anti-microbial peptide produced by T cells in response to SE. Accordingly, we propose that IL-26 producing T cells take part in the innate immune response to SE producing S. aureus and thus play a novel role in the primary innate immune defense in addition to their classical role in adaptive immunity.

Original languageEnglish
JournalOncotarget
Volume9
Issue number28
Pages (from-to)19481-19489
Number of pages9
ISSN1949-2553
DOIs
Publication statusPublished - 13 Apr 2018

ID: 55803472